Cancer vaccines are showing promise at last
Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.
Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.
Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.
In The Conversation Drs. John Ligon and Christina von Roemeling discuss new paper they co-authored in the journal Cell.
UF-developed mRNA vaccine quickly reprogrammed the immune system to attack glioblastoma.
Study details novel method to create personalized mRNA-based vaccines to target brain tumors.
Dr. Jianping Huang and colleagues publish paper in the journal Acta Biomaterialia.
Fifth annual ReMission Summit brought together top brain tumor researchers and clinicians to advance new treatments.
Videos aired during The V Foundation's "V Week" highlight UF Health’s efforts to fight brain cancer.
Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.
UF researchers provide new insight into the makeup of glioblastoma cells and potential targets for interventions.